Treatment of COVID-19: old tricks for new challenges.
作者信息
Cunningham Anne Catherine, Goh Hui Poh, Koh David
机构信息
Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB), Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong, BE1410, Brunei.
Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
出版信息
Crit Care. 2020 Mar 16;24(1):91. doi: 10.1186/s13054-020-2818-6.
Abstract
摘要
相似文献
1
Treatment of COVID-19: old tricks for new challenges.
Crit Care. 2020 Mar 16;24(1):91. doi: 10.1186/s13054-020-2818-6.
2
COVID-19: Main therapeutic options.
Tunis Med. 2020 Apr;98(4):299-303.
3
Convalescent Plasma: Promise for COVID-19 Pandemic.
J Coll Physicians Surg Pak. 2020 Jun;30(6):88. doi: 10.29271/jcpsp.2020.Supp1.S88.
4
The resurgence of convalescent plasma therapy.
Lancet Haematol. 2020 May;7(5):e353. doi: 10.1016/S2352-3026(20)30117-4.
5
Audio Interview: Capitalizing on Immune Responses to Covid-19.
N Engl J Med. 2020 May 21;382(21):e93. doi: 10.1056/NEJMe2019020.
6
Editorial: Information on the COVID-19 Pandemic continued.
Transfus Apher Sci. 2020 Aug;59(4):102854. doi: 10.1016/j.transci.2020.102854. Epub 2020 Jun 26.
7
Clinical findings in a patient with haemophilia A affected by COVID-19.
Haemophilia. 2020 Jul;26(4):e214-e216. doi: 10.1111/hae.14000. Epub 2020 Apr 13.
8
Use of convalescent plasma in COVID-19 patients in China.
Transfus Clin Biol. 2020 Aug;27(3):168-169. doi: 10.1016/j.tracli.2020.05.001. Epub 2020 May 16.
9
Plasma Therapies and Parabiosis in the COVID-19 Era.
J Am Med Dir Assoc. 2020 Jul;21(7):994-995. doi: 10.1016/j.jamda.2020.05.066. Epub 2020 Jun 16.
10
Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.
Clin Transl Sci. 2020 Sep;13(5):835-837. doi: 10.1111/cts.12816. Epub 2020 Jun 26.
引用本文的文献
1
Trends and outcomes of heart failure hospitalizations during COVID-19 pandemic.
BMC Public Health. 2025 Mar 4;25(1):864. doi: 10.1186/s12889-025-21995-y.
2
Survey on the Traditional Use of Medicinal Herbs in Haiti: A Study on Knowledge, Practices, and Efficacy Prevention.
Plants (Basel). 2024 Aug 26;13(17):2383. doi: 10.3390/plants13172383.
3
Efficacy of lignocaine nebulization in patients with COVID-19 respiratory infection: An exploratory randomized double-blinded controlled trial.
J Anaesthesiol Clin Pharmacol. 2024 Apr-Jun;40(2):271-275. doi: 10.4103/joacp.joacp_205_22. Epub 2024 May 16.
4
A narrative review on adverse drug reactions of COVID-19 treatments on the kidney.
Open Med (Wars). 2024 Mar 15;19(1):20230867. doi: 10.1515/med-2023-0867. eCollection 2024.
5
Passive antibody therapy in emerging infectious diseases.
Front Med. 2023 Dec;17(6):1117-1134. doi: 10.1007/s11684-023-1021-y. Epub 2023 Dec 2.
6
Aptamer-Based Strategies to Address Challenges in COVID-19 Diagnosis and Treatments.
Interdiscip Perspect Infect Dis. 2023 Jul 31;2023:9224815. doi: 10.1155/2023/9224815. eCollection 2023.
7
Risk Factors for Severity and Mortality in Adult Patients Confirmed with COVID-19 in Sierra Leone: A Retrospective Study.
Infect Dis Immun. 2022 Jan 13;2(2):83-92. doi: 10.1097/ID9.0000000000000037. eCollection 2022 Apr.
8
In silico transcriptional analysis of asymptomatic and severe COVID-19 patients reveals the susceptibility of severe patients to other comorbidities and non-viral pathological conditions.
Hum Gene (Amst). 2023 Feb;35:201135. doi: 10.1016/j.humgen.2022.201135. Epub 2022 Dec 16.
9
Interaction of Biochemical Processes between Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension (PAH), and Coronavirus Disease 2019 (COVID-19).
Pol J Microbiol. 2023 Jun 14;72(2):143-154. doi: 10.33073/pjm-2023-015. eCollection 2023 Jun 1.
10
Identification of the ideal recruitment situation in pandemic research: learning from the RECOVERY trial in Northern England: a qualitative study.
BMJ Lead. 2023 Jun;7(2):108-116. doi: 10.1136/leader-2021-000566. Epub 2022 Oct 23.
本文引用的文献
1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. Epub 2020 Feb 17.
2
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
3
Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China.
Crit Care. 2020 Feb 19;24(1):56. doi: 10.1186/s13054-020-2786-x.
4
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.
Chin J Integr Med. 2020 Apr;26(4):243-250. doi: 10.1007/s11655-020-3192-6. Epub 2020 Feb 17.
5
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia.
Emerg Infect Dis. 2016 Sep;22(9):1554-61. doi: 10.3201/eid2209.151164.
6
Convalescent plasma: new evidence for an old therapeutic tool?
Blood Transfus. 2016 Mar;14(2):152-7. doi: 10.2450/2015.0131-15. Epub 2015 Nov 6.
7
The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.
J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16.
8
Hyperimmune globulins and same-day thrombotic adverse events as recorded in a large healthcare database during 2008-2011.
Am J Hematol. 2013 Dec;88(12):1035-40. doi: 10.1002/ajh.23559. Epub 2013 Sep 12.
Zotero 插件